3rd COINS International Symposium "Towards Smart Health Society - Challenge of Kawasaki based Medical Innovation -"
Results of a Phase Ib Clinical Study of NC-6004 in the US
Commencement of investigator-initiated clinical trial of stroke patients using HAL® for Medical Use (Single-Leg Model) ~Step towards the medical device approval and expansion of Cybernic treatment~
KINGSKYFRONT region is selected as Wellbeing Research Campus
"PeptiDream Announces Start of Preclinical Testing of Anti-Influenza Candidate PD-001"
Under the supervision of medical professionals, the manual for proper usage of HAL® for Medical Use (Lower Limb Type) has now been published ~ Commencement of the world’s first insured robotic treatment covered under general public health insurance ~
Ceremony to commemorate the completion of the Create Medic Research and Development Center
NanoCarrier Co., Ltd. announces start of phase one clinical trials in Taiwan of drug delivery product for treatment of head and neck cancer.
Application for national health insurance coverage for HAL for Medical Use (Lower Limb Type) submitted to the Ministry of Health, Labour and Welfare
KINGSKYFRONT area is selected as a ‘feasibility hub’ by the Japan Science and Technology Agency (JST)
HAL for Medical Use (Lower Limb Type) received approval to be manufactured and sold as a medical device by the Ministry of Health, Labour and Welfare
KINGSKYFRONT concept images updated
Fujifilm establishes “Cellular Dynamics International Japan” to launch iPSC business for drug discovery support in Tonomachi (Kawasaki, Japan)
Next Generation Robots Introduced to Haneda Airport Domestic Passenger Terminal! ~HAL® for Labor Support (Lumbar type), Transport Robot, and Cleaning Robot Commence Operations~
Novel Norovirus Strain Identified by Kawasaki City Institute for Public Health
Johnson & Johnson K.K. First Anniversary of Tokyo Science Center, a Training Center for Healthcare Professionals - The number of visitors from home and abroad exceeds 22,000 -
Opening Ceremony of Innovation Center of NanoMedicine (iCONM)
PeptiDream Inc., announces the opening of facilities at KAWASAKI KING SKYFRONT.
Kazunori Kataoka and colleagues publish paper on ‘chemical surgery’ for cancer treatment.
Solvay opens research and innovation laboratory at LiSE, KING SKYFRONT.
Bridge across Tamagawa River to link Haneda Airport to KING SKYFRONT
Professor Kazunori Kataoka, Tokyo University and the Director, Innovation Center of NanoMedicine(iCONM) received 2015 Gutenberg Research Award.
Professor Kataoka and colleagues at the COINS（Center of Open Innovation Network for Smart Health） describe their latest findings in the following paper:
Launch of the Innovation Center of NanoMedicine (iCONM) led by Professor Kazunori Kataoka, at KING SKYFRONT.
Toshiba Ltd and Kawasaki City develop a rapid and efficient DNA chip technology for simultaneously testing 14 major types of food borne pathogens in less than 90 minutes.
CYBERDYNE Inc. submitted final application for market clearance from the U.S. Food and Drug Administration (“FDA”) ~ the first DeNovo submission by a Japanese company for a “novel” medical device
HAL received the world-first certificates of an international safety standard as wearable robots for workers and caregivers
Herbert Lauterbach Award 2014 to Bergmannsheil Bochum for HAL- exoskeleton research
Fujifilm enters the PET (positron emission tomography) radiopharmaceutical market
Central Institute for Experimental Animals featured in Nature article
CYBERDYNE Inc. launched HAL® for Task Support to enter fields of heavy work assistance devices
Article regarding efficacy of HAL For Medical Use was published in US medical magazine “Neurology”
FUJIFILM RI Pharma Co., Ltd. and CYBERDYNE Inc announce that they will open facilities at KAWASAKI KING SKYFRONT.
Johnson & Johnson Opens Tokyo Science Center
Daiwa House Signs Land Transfer Agreement with Urban Renaissance Agency and Memorandum with Kawasaki Municipal Government
Professor Kazunori Kataoka of the University of Tokyo and Center of Open Innovation Network for Smart Health (COINS) is selected by Thompson Reuters as a ‘highly cited researcher for 2014’.
Comprehensive Agreement signed by Kawasaki Municipal Government and CYBERDYNE
Keio Team to Start World’s First Clinical Trail of New Spinal Injury Treatment
Central Institute for Experimental Animals Signed Memorandum of Understanding with United Graduate School of Veterinary Sciences, Gifu University
Hirofumi Shiono Section Manager1st Development Section1st Development DepartmentMedical Business Development Division NIKON CORPORATION